Inhaled or oral corticosteroids remain the most effective treatment for COPD, which has been proved to effectively inhibit NF-κB activation in vitro and in vivo (Issa et al., 2007; Salter et al., 2007). This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.